Live simian immunodeficiency virus vaccine correlate of protection: Immune complex-inhibitory fc receptor interactions that reduce target cell availability

Journal of Immunology

Volumn 193, Issue 6, 2014, Pages 3126-3133

  Smith, Anthony J ^a,k   Wietgrefe, Stephen W ^a   Shang, Liang ^a   Reilly, Cavan S ^b   Southern, Peter J ^a   Perkey, Katherine E ^a   Duan, Lijie ^a   Kohler, Heinz ^c   Müller, Sybille ^d   Robinson, James ^e   Carlis, John V ^f   Li, Qingsheng ^g   Johnson, R Paul ^h,i,j,l   Haase, Ashley T ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d Immpheron Incorporated   (United States)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f University of Minnesota   (United States)

^g UNIVERSITY OF NEBRASKA   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

^k Manipal Education Americas   (United States)

^l EMORY UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; FC RECEPTOR IIB; IMMUNOGLOBULIN G ANTIBODY; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; ANTIGEN ANTIBODY COMPLEX; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN G; LIVE VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; INNATE IMMUNITY; MALE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; UTERINE CERVIX EPITHELIUM; VIRUS ENTRY; ANIMAL; BIOSYNTHESIS; CELL MOTION; FEMALE; GENE EXPRESSION PROFILING; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MUCOSA; SIMIAN IMMUNODEFICIENCY VIRUS; UTERINE CERVIX; VACCINATION; VAGINA; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGEN-ANTIBODY COMPLEX; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CERVIX UTERI; FEMALE; GENE EXPRESSION PROFILING; HIV ENVELOPE PROTEIN GP41; IMMUNITY, INNATE; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MUCOUS MEMBRANE; RECEPTORS, IGG; SAIDS VACCINES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINATION; VACCINES, ATTENUATED; VAGINA;

EID: 84921689175     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400822     Document Type: Article

References (26)

1. Auvert, B., D. Taljaard, E. Lagarde, J. Sobngwi-Tambekou, R. Sitta, and A. Puren. 2005. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2: e298.
2. Grant, R. M., J. R. Lama, P. L. Anderson, V. McMahan, A. Y. Liu, L. Vargas, P. Goicochea, M. Casapía, J. V. Guanira-Carranza, M. E. Ramirez-Cardich, et al; iPrEx Study Team. 2010. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. 363: 2587-2599.
3. Abdool Karim, Q., S. S. Abdool Karim, J. A. Frohlich, A. C. Grobler, C. Baxter, L. E. Mansoor, A. B. M. Kharsany, S. Sibeko, K. P. Mlisana, Z. Omar, et al; CAPRISA 004 Trial Group. 2010. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329: 1168-1174.
4. Daniel, M. D., F. Kirchhoff, S. C. Czajak, and P. K. Sehgal, and R. C. Desrosiers. 1992. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258: 1938-1941.
5. Johnson, R. P. 1999. Live attenuated AIDS vaccines: hazards and hopes. Nat. Med. 5: 154-155.
6. Koff, W. C., P. R. Johnson, D. I. Watkins, D. R. Burton, J. D. Lifson, K. J. Hasenkrug, A. B. McDermott, A. Schultz, T. J. Zamb, R. Boyle, and R. C. Desrosiers. 2006. HIV vaccine design: insights from live attenuated SIV vaccines. Nat. Immunol. 7: 19-23.
7. Li, Q., M. Zeng, L. Duan, J. E. Voss, A. J. Smith, S. Pambuccian, L. Shang, S. Wietgrefe, P. J. Southern, C. S. Reilly, et al. 2014. Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry. J. Immunol. 193: 3113-3125.
8. Miller, C. J., Q. Li, K. Abel, E.-Y. Kim, Z.-M. Ma, S. Wietgrefe, L. La Franco-Scheuch, L. Compton, L. Duan, M. D. Shore, et al. 2005. Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. [Published erratum appears in 2005 J. Virol. 79: 11552.] J. Virol. 79: 9217-9227.
9. Smith, A. J., Q. Li, S. W. Wietgrefe, T. W. Schacker, C. S. Reilly, and A. T. Haase. 2010. Host genes associated with HIV-1 replication in lymphatic tissue. J. Immunol. 185: 5417-5424.
10. Smith, A. J., T. W. Schacker, C. S. Reilly, and A. T. Haase. 2010. A role for syndecan-1 and claudin-2 in microbial translocation during HIV-1 infection. J. Acquir. Immune Defic. Syndr. 55: 306-315.
11. Haase, A. T. 2010. Targeting early infection to prevent HIV-1 mucosal transmission. Nature 464: 217-223.
12. + T cells. [Published erratum appears in 1999 Science 286: 2273.] Science 286: 1353-1357.
13. Li, Q., J. D. Estes, P. M. Schlievert, L. Duan, A. J. Brosnahan, P. J. Southern, C. S. Reilly, M. L. Peterson, N. Schultz-Darken, K. G. Brunner, et al. 2009. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458: 1034-1038.
14. You, F., H. Sun, X. Zhou, W. Sun, S. Liang, Z. Zhai, and Z. Jiang. 2009. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat. Immunol. 10: 1300-1308.
15. Zhou, X., F. You, H. Chen, and Z. Jiang. 2012. Poly(C)-binding protein 1 (PCBP1) mediates housekeeping degradation of mitochondrial antiviral signaling (MAVS). Cell Res. 22: 717-727.
16. Yoshimura, A. 2009. Regulation of cytokine signaling by the SOCS and Spred family proteins. Keio J. Med. 58: 73-83.
17. Akbulut, S., A. L. Reddi, P. Aggarwal, C. Ambardekar, B. Canciani, M. K. Kim, L. Hix, T. Vilimas, J. Mason, M. A. Basson, et al. 2010. Sprouty proteins inhibit receptor-mediated activation of phosphatidylinositol-specific phospholipase C. Mol. Biol. Cell 21: 3487-3496.
18. Burstein, E., J. E. Hoberg, A. S. Wilkinson, J. M. Rumble, R. A. Csomos, C. M. Komarck, G. N. Maine, J. C. Wilkinson, M. W. Mayo, and C. S. Duckett. 2005. COMMD proteins, a novel family of structural and functional homologs of MURR1. J. Biol. Chem. 280: 22222-22232.
19. Maine, G. N., and E. Burstein. 2007. COMMD proteins and the control of the NF kappa B pathway. Cell Cycle 6: 672-676.
20. Delerive, P., D. Monté, G. Dubois, F. Trottein, J. Fruchart-Najib, J. Mariani, J. C. Fruchart, and B. Staels. 2001. The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. EMBO Rep. 2: 42-48.
21. Dzhagalov, I., N. Zhang, and Y. W. He. 2004. The roles of orphan nuclear receptors in the development and function of the immune system. Cell. Mol. Immunol. 1: 401-407.
22. Nimmerjahn, F., and J. V. Ravetch. 2007. Fc-receptors as regulators of immunity. Adv. Immunol. 96: 179-204.
23. Wang, H., S. Müller, S. Zolla-Pazner, and H. Köhler. 1992. Human monoclonal and polyclonal anti-human immunodeficiency virus-1 antibodies share a common clonotypic specificity. Eur. J. Immunol. 22: 1749-1755.
24. Müller, S., D. H. Margolin, and G. Min. 1997. An HIV-1 infection-related idiotype/clonotype (1F7) is expressed on antibodies directed to envelope glycoprotein in simian immunodeficiency virus- and chimeric simian/human immunodeficiency virus-infected rhesus monkeys. Hybridoma 16: 17-21.
25. Southern, P. J., J. E. Horbul, B. R. Miller, and D. M. Maher. 2011. Coming of age: reconstruction of heterosexual HIV-1 transmission in human ex vivo organ culture systems. Mucosal Immunol. 4: 383-396.
26. Cole, K. S., M. Alvarez, D. H. Elliott, H. Lam, E. Martin, T. Chau, K. Micken, J. L. Rowles, J. E. Clements, M. Murphey-Corb, et al. 2001. Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain. Virology 290: 59-73.